K, H. S., Samar, T., & H, H. A. (2023). Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients. De Gruyter.
芝加哥风格引文K, Hegazy Sahar, Tharwat Samar, 与 Hassan Ahmed H. Study to Compare the Effect of Casirivimab and Imdevimab, Remdesivir, and Favipiravir on Progression and Multi-organ Function of Hospitalized COVID-19 Patients. De Gruyter, 2023.
MLA引文K, Hegazy Sahar, et al. Study to Compare the Effect of Casirivimab and Imdevimab, Remdesivir, and Favipiravir on Progression and Multi-organ Function of Hospitalized COVID-19 Patients. De Gruyter, 2023.
警告：这些引文格式不一定是100％准确.